EXTRAWELL PHAR(00858) released its interim results with a net loss attributable to shareholders of HK$460 million, a year-on-year change from profit to loss.

23:12 28/11/2025

Jingyou Pharmaceutical (00858) released its interim results for the six months ended September 30, 2025, with a revenue of 28.008 million Hong Kong dollars, a decrease of 9.04% year-on-year; shareholders' attributable loss of 460 million Hong Kong dollars, a year-on-year change from profit to loss; loss per share of 19.09 Hong Kong cents.

EXTRAWELL PHAR (00858) has reported its interim performance for the six months ending September 30, 2025, with a revenue of HK$280.8 million, a decrease of 9.04% year-on-year; shareholders' net loss was HK$460 million, a turnaround from profit to loss; loss per share was 19.09 HK cents.

US Stock Market Move | Signed a strategic distribution agreement with WT Microelectronics, NaVi Technologies Semiconductor (NVTS.US) rose nearly 8% in early trading.

US Stock Market Move | Intel Corporation (INTC.US) rose more than 6.5%. Alphabet Inc. Class CTPU's demand expansion may be good for its foundry layout.

NIU HOLDINGS (08619) announced its interim results with a net profit of HK$11.988 million, a decrease of 37.71% year-on-year.

US Stock Market Move | Signed a strategic distribution agreement with WT Microelectronics, NaVi Technologies Semiconductor (NVTS.US) rose nearly 8% in early trading.

US Stock Market Move | Intel Corporation (INTC.US) rose more than 6.5%. Alphabet Inc. Class CTPU's demand expansion may be good for its foundry layout.

NIU HOLDINGS (08619) announced its interim results with a net profit of HK$11.988 million, a decrease of 37.71% year-on-year.